| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 287 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.338 |
| Gross Profit/Loss - EUR | 0 | -287 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.338 |
| Net Profit/Loss - EUR | 0 | -287 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.338 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Hemartex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.747 | 7.433 | 7.307 | 7.173 | 7.034 | 6.900 | 6.747 | 6.768 | 6.748 | 4.372 |
| Inventories | 11 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 0 |
| Receivables | 7.658 | 7.421 | 7.295 | 7.161 | 7.023 | 6.890 | 6.737 | 6.758 | 6.737 | 4.372 |
| Cash | 77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | 5.779 | 5.433 | 5.341 | 5.243 | 5.142 | 5.044 | 4.932 | 4.948 | 4.933 | 2.567 |
| Social Capital | 574 | 568 | 558 | 548 | 537 | 527 | 515 | 517 | 516 | 513 |
| Debts | 1.968 | 1.999 | 1.965 | 1.929 | 1.892 | 1.856 | 1.815 | 1.821 | 1.815 | 1.805 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7711 - 7711" | |||||||||
| CAEN Financial Year |
7711
|
|||||||||
Comments - Hemartex Srl